Younger consumers today are increasingly seeking cosmetic procedures to prevent the onset of expression lines, with botulinum toxin injections being a popular choice. Lubrizol Life Science Beauty (LLS Beauty) has developed an exciting alternative based on its time-tested Argireline® peptide.

For over 20 years, the original Argireline® peptide has been the go-to ingredient for those looking to smooth out wrinkles and now, the new Argireline® YOUth peptide can be expanded to new applications, including oil-based skincare especially. transparent serums, oils and sticks. This is thanks to the LipoClear™ inverse micelle delivery system which allows for the creation of an oil soluble active ingredient.

Argireline® YOUth peptide shows remarkable efficacy in the greatest areas of concern among younger adults, which has been validated by testing the new active ingredient among this group. Volunteers of Caucasian and Latin American descent between the ages of 19 and 35 were given a makeup foundation with 2% Argireline® YOUth peptide oil solution to apply daily. Volunteers of Asian descent between the ages of 25 and 40 were given an oil serum with 0.8% Argireline® YOUth peptide to apply daily.

Results of the in vivo efficacy testing of Argireline® YOUth peptide include:

- Minimized appearance of expression lines, without compromising the smile expression.
- Shorter and less visible wrinkles around the eyes.
- Smoother skin around the eyes and in the nasolabial and forehead regions.
- Minimized appearance of “tech neck” lines.

To measure some of the results, LLS Beauty developed a proprietary Deep Learning technology to objectively quantify a smile. Using SmiLearningTM smile rating technology, volunteers were asked to smile according to the satisfaction of their skin after treatment. With the active ingredient treatment, volunteers registered a 22% bigger smile, compared to placebo.